BACKGROUND: Tolerance to noninherited maternal antigens has provided clinical advantage when kidney transplants are exchanged between siblings but not when mother herself is the donor. This paradox prompted us to revisit the "two-way" hypothesis of transplant tolerance--that the immune status of both the organ recipient and the organ donor critically influences allograft outcome. METHODS: We obtained peripheral blood monocyte cells from 29 living donor-recipient pairs before transplant and used the trans-vivo-delayed type hypersensitivity assay to measure immune regulation in both the recipient antidonor and donor antirecipient directions. RESULTS: We found preexisting bidirectional regulation in all human leukocyte antigen (HLA)-identical sibling pairs tested (7/7), and one half (9/18) of the HLA haploidentical pairs. No significant regulation was found in four control living unrelated and two HLA haploidentical living-related donor recipient pairs, whereas unidirectional regulation was found in the remaining seven haploidentical pairs. Of the nine HLA haploidentical transplants with unidirectional or no pretransplant regulation, seven had an acute rejection episode and four of these experienced graft loss. In contrast, of the nine HLA haploidentical transplants with bidirectional regulation, only one had rejection. Renal function for the latter group was similar to HLA-identical kidney recipients at 3 years posttransplant. Significantly (P<0.05) lower mean serum creatinine values in bidirectional regulators were noted as early as 4 months and this difference became more pronounced at 12 (P<0.005) and 36 months (P<0.0001). CONCLUSIONS: Contrary to the belief that only the recipient's immune status matters, the data indicate that pretransplant immune status of both donor and recipient influence posttransplant outcome.
BACKGROUND: Tolerance to noninherited maternal antigens has provided clinical advantage when kidney transplants are exchanged between siblings but not when mother herself is the donor. This paradox prompted us to revisit the "two-way" hypothesis of transplant tolerance--that the immune status of both the organ recipient and the organ donor critically influences allograft outcome. METHODS: We obtained peripheral blood monocyte cells from 29 living donor-recipient pairs before transplant and used the trans-vivo-delayed type hypersensitivity assay to measure immune regulation in both the recipient antidonor and donor antirecipient directions. RESULTS: We found preexisting bidirectional regulation in all human leukocyte antigen (HLA)-identical sibling pairs tested (7/7), and one half (9/18) of the HLA haploidentical pairs. No significant regulation was found in four control living unrelated and two HLA haploidentical living-related donor recipient pairs, whereas unidirectional regulation was found in the remaining seven haploidentical pairs. Of the nine HLA haploidentical transplants with unidirectional or no pretransplant regulation, seven had an acute rejection episode and four of these experienced graft loss. In contrast, of the nine HLA haploidentical transplants with bidirectional regulation, only one had rejection. Renal function for the latter group was similar to HLA-identical kidney recipients at 3 years posttransplant. Significantly (P<0.05) lower mean serum creatinine values in bidirectional regulators were noted as early as 4 months and this difference became more pronounced at 12 (P<0.005) and 36 months (P<0.0001). CONCLUSIONS: Contrary to the belief that only the recipient's immune status matters, the data indicate that pretransplant immune status of both donor and recipient influence posttransplant outcome.
Authors: T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung Journal: Hepatology Date: 1993-06 Impact factor: 17.425
Authors: Chuanmin Wang; Shaun Cordoba; Min Hu; Patrick Bertolino; David G Bowen; Alexandra F Sharland; Richard D M Allen; Stephen I Alexander; Geoffrey W McCaughan; G Alex Bishop Journal: Transpl Immunol Date: 2011-01-01 Impact factor: 1.708
Authors: Daniëlle E M van den Boogaardt; Paula P M C van Miert; Karin M Koekkoek; Yvonne J H de Vaal; Jon J van Rood; Frans H J Claas; Dave L Roelen Journal: Hum Immunol Date: 2006-03-24 Impact factor: 2.850
Authors: Jon J van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz Journal: Blood Date: 2002-03-01 Impact factor: 22.113
Authors: Clifford D Miles; Douglas E Schaubel; Dandan Liu; Friedrich K Port; Panduranga S Rao Journal: Transplantation Date: 2008-05-27 Impact factor: 4.939
Authors: Astrid G S van Halteren; Ewa Jankowska-Gan; Antoinette Joosten; Els Blokland; Jos Pool; Anneke Brand; William J Burlingham; Els Goulmy Journal: Blood Date: 2009-06-08 Impact factor: 22.113
Authors: W J Burlingham; A P Grailer; J H Fechner; S Kusaka; M Trucco; M Kocova; F O Belzer; H W Sollinger Journal: Transplantation Date: 1995-04-27 Impact factor: 4.939
Authors: William Bracamonte-Baran; Jonathan Florentin; Ying Zhou; Ewa Jankowska-Gan; W John Haynes; Weixiong Zhong; Todd V Brennan; Partha Dutta; Frans H J Claas; Jon J van Rood; William J Burlingham Journal: Proc Natl Acad Sci U S A Date: 2017-01-17 Impact factor: 11.205
Authors: Jeremy A Sullivan; Yusuke Tomita; Ewa Jankowska-Gan; Diego A Lema; Matt P Arvedson; Ashita Nair; William Bracamonte-Baran; Ying Zhou; Kristy K Meyer; Weixiong Zhong; Deepali V Sawant; Andrea L Szymczak-Workman; Qianxia Zhang; Creg J Workman; Seungpyo Hong; Dario A A Vignali; William J Burlingham Journal: Cell Rep Date: 2020-01-28 Impact factor: 9.423
Authors: Ekaterina V Putintseva; Olga V Britanova; Dmitriy B Staroverov; Ekaterina M Merzlyak; Maria A Turchaninova; Mikhail Shugay; Dmitriy A Bolotin; Mikhail V Pogorelyy; Ilgar Z Mamedov; Vlasta Bobrynina; Mikhail Maschan; Yuri B Lebedev; Dmitriy M Chudakov Journal: Front Immunol Date: 2013-12-25 Impact factor: 7.561